| Tretinoin | Approved Investigational Nutraceutical | GEMIN6 | 79833 |
downregulated | Tretinoin results in decreased expression of GEMIN6 mRNA | 2p22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | GFAP | 2670 |
upregulated | Tretinoin results in increased expression of GFAP mRNA | 17q21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | GFI1 | 2672 |
downregulated | Tretinoin results in decreased expression of GFI1 mRNA | 1p22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | GFPT1 | 2673 |
downregulated | Tretinoin results in decreased expression of GFPT1 mRNA | 2p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GFPT2 | 9945 |
downregulated | Tretinoin results in decreased expression of GFPT2 mRNA | 5q35.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GFPT2 | 9945 |
upregulated | Tretinoin results in increased expression of GFPT2 mRNA | 5q35.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GFRA2 | 2675 |
upregulated | Tretinoin results in increased expression of GFRA2 mRNA | 8p21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GGT1 | 2678 |
upregulated | Tretinoin results in increased expression of GGT1 mRNA | 22q11.23 | |
| Tretinoin | Approved Investigational Nutraceutical | GGT2 | 728441 |
upregulated | Tretinoin results in increased expression of GGT2 mRNA | 22q11.21 | |
| Tretinoin | Approved Investigational Nutraceutical | GHR | 2690 |
upregulated | Tretinoin results in increased expression of GHR mRNA | 5p13.1-p12 | |
| Tretinoin | Approved Investigational Nutraceutical | GIN1 | 54826 |
downregulated | Tretinoin results in decreased expression of GIN1 mRNA | 5q21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | GINS1 | 9837 |
downregulated | Tretinoin results in decreased expression of GINS1 mRNA | 20p11.21 | |
| Tretinoin | Approved Investigational Nutraceutical | GINS2 | 51659 |
downregulated | Tretinoin results in decreased expression of GINS2 mRNA | 16q24.1 | |
| Tretinoin | Approved Investigational Nutraceutical | GINS3 | 64785 |
downregulated | Tretinoin results in decreased expression of GINS3 mRNA | 16q21 | |
| Tretinoin | Approved Investigational Nutraceutical | GJA1 | 2697 |
downregulated | Tretinoin results in decreased expression of GJA1 mRNA | 6q22.31 | |
| Tretinoin | Approved Investigational Nutraceutical | GJA5 | 2702 |
upregulated | Tretinoin results in increased expression of GJA5 mRNA | 1q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | GJB1 | 2705 |
upregulated | Tretinoin results in increased expression of GJB1 mRNA | Xq13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | GJB2 | 2706 |
upregulated | Tretinoin results in increased expression of GJB2 mRNA | 13q12.11 | |
| Tretinoin | Approved Investigational Nutraceutical | GJB6 | 10804 |
upregulated | Tretinoin results in increased expression of GJB6 mRNA | 13q12.11 | |
| Tretinoin | Approved Investigational Nutraceutical | GLB1 | 2720 |
upregulated | Tretinoin results in increased expression of GLB1 mRNA | 3p22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GLCCI1 | 113263 |
downregulated | Tretinoin results in decreased expression of GLCCI1 mRNA | 7p21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GLCE | 26035 |
upregulated | Tretinoin results in increased expression of GLCE mRNA | 15q23 | |
| Tretinoin | Approved Investigational Nutraceutical | GLDC | 2731 |
downregulated | Tretinoin results in decreased expression of GLDC mRNA | 9p24.1 | |
| Tretinoin | Approved Investigational Nutraceutical | GLI2 | 2736 |
downregulated | Tretinoin results in decreased expression of GLI2 mRNA | 2q14.2 | |
| Tretinoin | Approved Investigational Nutraceutical | GLIPR2 | 152007 |
upregulated | Tretinoin results in increased expression of GLIPR2 mRNA | 9p13.3 | |